Background
Talaromyces (formerly
Penicillium) marneffei (T. marneffei) is an opportunistic pathogen that infects immunodeficient patients in Southeast Asia as a dimorphic fungus. The fungus was first isolated from the hepatic lesions of a bamboo rat (
Rhizomys sinensis) that died spontaneously from the infection in 1956 [
1]. Subsequent studies showed that bamboo rats (
Rhizomys sp. and
Cannomys sp.) and soil from their burrows were important enzootic and environmental reservoirs of
T. marneffei, respectively [
2]. Generally,
T. marneffei presented either as a local or disseminated infection. The symptoms and signs of disseminated
T. marneffei typically include fever, weight loss, fatigue, hepatosplenomegaly, lymphadenopathy, respiratory, and gastrointestinal abnormalities, and is associated with serious complications and high death rates [
3]. In adults,
T. marneffei infection has been considered to be exclusively associated with acquired immunodeficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV) infection [
4]. Therefore, the close correlation between disease manifestation and severity with CD4+ cell count confirms the importance of cell-mediated immunity against
T. marneffei in adults [
2,
5].
The proportion of patients aged 3 months to 16 years among reported cases of
talaromycosis, is approximately 6–7.5% [
6‐
8]. Unlike the previous reports with most HIV-infected pediatric cases, recent studies showed most pediatric patients were HIV negative [
6,
8].. At present, the research on the peripheral immune profile is less comparatively in HIV-negative children with
T. marneffei infections. In the previous study, the HIV-negative children had a reduction in the number of T-lymphocytes or cellular immunity is probably the most important predisposing factor for
T. marneffei infection [
6]. However, the current knowledge gaps focus on the immune statuses of these children and the categories of primary immunodeficiencies (PIDs) associated with
T. marneffei infections.
This retrospective study of 21 HIV-negative children who were infected by T. marneffei preliminarily assess the immune profile of these patients and to provide insights into the immunological characteristics of the disease in children.
Methods
A retrospective cohort study was conducted from January 2010 to January 2020 at Guangzhou Women and Children’s Medical Center. Twenty-one children enrolled in this study who presented with culture and/or histopathologically proven infections caused by T. marneffei. All data were collected using a standardized form that was based entirely on the medical reports of each patient. The data included demographic information, domiciles, medical history, clinical manifestations, immunologic detection, genetic tests, complications and prognosis.
The diagnostics of PIDs were performed based on clinical characteristics and genetic tests according to the updated classification of PIDs by the Primary Immunodeficiency Expert Committee (PID EC) of the International Union of Immunological Societies (IUIS) [
9]. As noted, the National Institutes of Health (NIH) developed a clinical Hyperimmunoglobulin E Syndromes (HIES) scoring system [
10], which can serve as a valuable reference for the diagnosis of HIES. The diagnostic criteria included increased IgE (> 1000 IU/mL) plus a weighted score of clinical features > 30 as diagnosis of autosomal dominant HIES (AD-HIES) [
11].
This study protocol was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Guangzhou Women and Children’s Medical Center of Guangzhou Medical University. We obtained all written informed consent from the children’s parents or legal guardians for the use of their clinical and laboratory data from their medical reports.
Discussion
Talaromyces (formerly
Penicillium) marneffei
(T. marneffei) is an opportunistic pathogen that infects immunodeficient children. The aim of the study is to determine the clinical features and peripheral immune state of
T. marneffei infections in children for early detection and diagnosis.
T. marneffei is an emerging pathogenic fungus that can cause fatal systemic mycosis in immunocompromised hosts and occurs mostly in humid tropical climate regions, including the south and southwest regions of China [
12]. In adult,
T. marneffei infection occurs mainly in AIDS patients, where it is a severe, deep mycosis with high mortality [
4]. In contrast to adults, subjects with PIDs are more susceptible in children according to previous reports [
6,
8]. Furthermore, the recognition of immune status by clinical observation is important to treat and prevent
T. marneffei infections in children and to facilitate the diagnosis and reporting of PIDs. We retrospectively analyzed the immunity status of 21 children with
T. marneffei infection over this decade, including the immunoglobulin pattern (IgG, IgA, IgM, and IgE) and enumeration of lymphocyte subpopulations (T-, B-, and NK-cells) in peripheral blood. We found that abnormal immunoglobulin findings were considerable in HIV-negative children with
T. marneffei infection, mainly in those with decreased IgG or increased IgE.
In our study, we summarized 21 documented pediatric cases of proven
T. marneffei infection in southern China. Most cases presented with fever, weight loss, swollen lymph nodes, generalized lymphadenopathy, and hepatomegaly. In many aspects, the clinical manifestations of pediatric patients are different from those of adult patients [
6,
8,
13]. For example, respiratory system involvement was also observed in most cases, but skin lesions were unusual in pediatric patients in the present study. A high frequency (70–80%) of skin lesions has been reported in adults with
T. marneffei infection [
14]. Nonspecific clinical manifestations are a potential cause of misdiagnosis for
T. marneffei infection.
T. marneffei infection is a severe disease that can lead to high mortality rates of greater than 50% in children in previous reports [
6]. Of these cases, 11 were fatal, and all fatal cases in our study died of serious complications, such as HLH, septic shock, MODS, DIC and ARDS. It is noteworthy that the incidence of HLH in pediatric patients was significantly higher than that in adults, possibly because many of our children had delayed treatment due to early misdiagnosis. Another major cause of complications and high mortality in HIV-negative patients with
T. marneffei infection may be abnormal host immune function.
In the present study, all of these children were HIV negative, but they almost had abnormal immune parameters at the time of diagnosis, especially in the immunoglobulin contents, including decreased levels of IgG or increased levels of IgE in peripheral blood. However, in only three cases, the number of peripheral blood lymphocytes significantly decreased. Previous studies have suggested that a reduction in the number of T lymphocytes or cellular immunity is probably the most important predisposing factor for adult
T. marneffei infection [
6,
7]. Serum antibody levels were increased in HIV-negative adults in one study [
15]. Unlike adults, the decreased levels of IgG in peripheral blood were found in 7 cases. There were 9 cases with increased IgE, two of them had markedly elevated IgE levels. Taking into account that 9 cases were treated by IVIg prior to the immune detection being performed, which certainly influenced immunoglobulin levels in peripheral blood. Even so, the common immunoglobulin changes in children with
T. marneffei infection are lower IgG or higher IgE in peripheral blood. That is, pediatricians should be alert to
T. marneffei infection in children when peripheral immunoglobulin changes.
On the other hand, abnormal immunity may occur secondary to serious
T. marneffei infection. Previous studies focused less on complement levels. In our study, approximately half of all patients displayed decreased complement levels, especially C3. It should be noted that of the 11 deaths of our children, 9 cases of complement dramatically declined. The complement system has a determinant role in defense against infections [
16], so the reduction in complement is probably also an important index of children with severe
T. marneffei infection. In addition, reduced NK cell counts were identified in most patients. NK cells are the prototype innate lymphoid cells endowed with potent cytolytic functions that provide host defense against microbial infection [
17]. The reduction in NK cells may be due to HLH secondary to severe
T. marneffei infection. Further studies are necessary to evaluate immunologic parameters to explore the influence of body immunity from severe
T. marneffei infection.
Abnormal immunological findings might suggest underlying PIDs in HIV-negative children with
T. marneffei infection. This point has been reported in children with various forms of immune-related underlying diseases and PIDs [
7,
18,
19]. As a further study of
T. marneffei infection, we performed nine genetic tests of underlying PIDs in recent years. The results showed that four cases were identified as HIGM with mutations or microdeletion of the
CD40LG gene. There were two patients with mutations in
STAT3 gene, one of whom was diagnosed with HIES in combination with typical clinical features. We have not diagnosed HIES in another child now, considering many clinical signs did not appear at his age (1 year old). His NIH score was only 20, but it was not completely excluded. A hemizygous mutation of
IL2RG was identified in one patient diagnosed with SCID. The immunoassay results of the patient displayed reduced numbers of lymphocyte subsets along with remarkable declines in immunoglobulin levels. This finding is consistent with
IL2RG mutation for definitive diagnosis. One patient had a mutated
COPA gene with uncertain pathogenic potential. Patients with
COPA mutations typically have normal numbers and percentages of lymphocytes and lymphocyte subsets along with unremarkable immunoglobulin levels and intact production of specific antibodies [
20]. However, the child had remarkedly decreased immunoglobulin with normal numbers of lymphocytes. The exact mechanism by which
COPA gene mutation causes
T. marneffei infection is currently unknown. Although no genetic testing was performed on 12 patients, some of them showed degrees of abnormal immunity in peripheral blood. Of note is patient 7. She was diagnosed with HIES based on her clinical features and the NIH scoring system, but she did not receive genetic tests. In addition, P2, P11, P12 and P13 were accompanied by a decrease in IgG levels, and P12 coincided with obviously reduced counts of lymphocyte subsets. This finding might suggest that these patients could have had potentially underlying immunodeficiencies that were not identified or that their poor prognosis was linked to a more systemic impairment in immunity.
The study still has some limitations that should be considered. This is a retrospective single-center analysis, and some earlier HIV-negative children with T. marneffei did not receive genetic tests; hence, the proportion of such cases with underlying PIDs is unknown. In addition, serum neutralizing anti-IFN-γ autoantibodies has not yet been carried out in our hospital, it is with great regret that our patients failed to get tested. Furthermore, anti-IFN-γ autoantibodies associated immunodeficiency is partly due to inherited mutations in IFN-γ-signaling-associated factors, however we such mutations were not detected in our small cohort. We will pay more attention to the disease and perform the testing in the future. Nevertheless, this study may provide a valuable reference for immunity monitoring in children with T. marneffei infection.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.